How An Infamous Party Drug Could Hold The Key To Quieting Suicidal Ideation

Scientists have been looking at ketamine's effects on suicidal thoughts for a while now, but no one was biting despite the positive trial results. With the rise of the suicide epidemic, however, the winds might be changing. The first ketamine-based drug, from Johnson & Johnson, could be approved for treatment-resistant depression by March and suicidal thinking within two years. In other public health news: supplements and dementia, gambling, aging and the brain, intimacy, gene-editing and more.

from Kaiser Health News http://bit.ly/2UCycSU